CRT-Pacemaker Versus CRT-Defibrillator Who Needs Sudden Cardiac Death Protection?

Area of Science:

• Cardiology
• Biomedical Engineering

Background:

• Patients with cardiomyopathy and reduced left ventricular (LV) ejection fraction face high risks of sudden cardiac death (SCD).
• Cardiac resynchronization therapy (CRT) improves cardiac function and reduces SCD risk in select heart failure patients.
• The need for concomitant implantable cardioverter-defibrillator (ICD) therapy in all CRT candidates is debatable.

Purpose of the Study:

• To review the residual risk of SCD in patients undergoing CRT.
• To discuss the necessity of ICD therapy for CRT candidates.

Main Methods:

• Review of current literature on CRT, SCD, and ICD therapy.
• Analysis of recent findings on advanced cardiac imaging techniques for risk stratification.

Main Results:

• CRT can significantly reduce ventricular arrhythmias and SCD.
• Advanced imaging, including cardiac CT and contrast-enhanced CMR for myocardial scar analysis, shows promise in predicting SCD risk in patients with biventricular pacing.
• These tools may help identify CRT candidates who require ICD protection.

Conclusions:

• Not all CRT candidates require concomitant ICD therapy.
• Cardiac imaging, particularly myocardial scar assessment, is emerging as a valuable tool for refining SCD risk stratification in CRT patients.
• Future strategies may leverage imaging to personalize ICD implantation decisions for CRT recipients.